News in the Life Sciences Industry

PHILADELPHIA, April 17, 2019 /PRNewswire/ -- Using CRISPR gene editing, a team from Children's Hospital of Philadelphia... Read more ››

DUBLIN, April 17, 2019 /PRNewswire/ -- The Read more ››

CINCINNATI, April 17, 2019 /PRNewswire/ -- Aprecia, the 3DP Pharmaceutical Company, today announced that Chris... Read more ››

TAMPA, Fla., April 17, 2019 /PRNewswire/ -- The Amgen Foundation, together with the University of South Florida (USF), today announced the launch of the Read more ››

NEW YORK, April 17, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase additional shares of its common stock... Read more ››

PALO ALTO, Calif., April 17, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering are to be sold by Eiger. In addition, Eiger expects... Read more ››

ALAMEDA, Calif., April 17, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2019 after market close on Tuesday, May 7, 2019 at 4:30 PM Eastern Time. A press release with first quarter 2019 financial... Read more ››

FLINT, Mich., April 17, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2019 operating results before market open Tuesday, May 7. A conference call and live webcast will be held at 8:30 a.m. ET.

ATLANTA, April 17, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 first quarter financial results will be released on Tuesday, April 30, 2019 after the market closes. On that day, the Company... Read more ››

WARREN, N.J., April 17, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that it will report results for the first quarter ended... Read more ››